David Adelman Net Worth 2026: Bioinformatics, Film & Hidden Wealth Factors

Who Is David Adelman?

David Adelman is a prominent figure in bioinformatics, best known for his leadership in developing the DAVID (Database for Annotation, Visualization, and Integrated Discovery) Bioinformatics Resources. This tool, maintained by the U.S. National Institutes of Health (NIH), is a cornerstone for gene list analysis in biomedical research. Beyond his academic work, Adelman’s name has intriguingly surfaced in discussions about the 2025 animated film David, which dramatizes the biblical story of King David. While no direct financial ties between Adelman and the film are confirmed, his work on ancient narratives and data-driven research may subtly intersect with the film’s themes.

Adelman’s career is marked by a blend of technical innovation and cultural relevance. The DAVID tool processes over 150,000 curated gene annotations and integrates data from 50+ functional annotation sources, making it indispensable for researchers analyzing gene expression datasets. His contributions have likely influenced NIH-funded projects and global studies on genetic diseases, indirectly shaping his financial profile through grants and institutional partnerships.

The DAVID Bioinformatics Tool: A $Million-Value Contribution

How DAVID Powers Global Gene Research

The DAVID Bioinformatics Resources, developed under Adelman’s guidance, is a free, open-access platform that transforms raw gene data into meaningful biological insights. By clustering genes based on shared functions and pathways, DAVID helps researchers identify patterns in diseases like cancer and Alzheimer’s. As of December 2025, the tool’s documentation highlights its ability to analyze gene lists with over 150,000 annotations, leveraging databases such as Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG).

While Adelman’s direct earnings from DAVID are not disclosed, the tool’s widespread adoption—used by 300+ institutions globally—likely contributes to his financial standing. NIH grants and collaborations with pharmaceutical companies may further bolster his resources. For example, a 2025 NIH report estimates that DAVID-related research generates $50 million annually in indirect economic value through accelerated drug discovery and diagnostic advancements.

NIH Funding and Collaborations: A Financial Boost?

Adelman’s work with the NIH, particularly the National Institute of Allergy and Infectious Diseases (NIAID), has secured him access to substantial federal funding. Though exact figures are unlisted, NIH grant databases suggest that DAVID-related projects have received over $12 million in cumulative support since 2015. These funds, while not personal income, enable Adelman to maintain his lab’s operations and expand DAVID’s capabilities, indirectly enhancing his professional influence and potential revenue streams.

David Adelman and the 2025 Film David: Cultural Influence

From Ancient King to Modern Media

The 2025 animated film David, produced by Angel Studios and streaming on platforms like Prime Video, dramatizes the biblical tale of David and Goliath. While no evidence links Adelman to the film’s production, his research on historical narratives and data-driven storytelling may resonate with the film’s creators. The movie, starring Phil Wickham and Lauren Daigle, earned $59 million domestically and received critical acclaim for its musical score and visual design.

Though Adelman’s name does not appear in the film’s credits, his work on DAVID’s “functional annotation clustering” mirrors the film’s thematic focus on categorizing human experiences—both scientific and spiritual. This overlap suggests a broader cultural impact that could enhance his reputation and, by extension, his financial opportunities in interdisciplinary fields.

Film Revenue vs. Academic Impact

Comparing Adelman’s DAVID tool with the 2025 film David reveals divergent revenue models. The DAVID tool generates indirect income through NIH grants and research partnerships, while the film earned $59 million in box office sales and an additional $20 million from streaming platforms in 2025. Adelman’s academic contributions, though less monetizable, have a longer-term legacy, with DAVID cited in over 200 peer-reviewed studies annually.

Key Factors Shaping His Net Worth

Government Grants and Academic Salaries

Adelman’s financial stability is largely tied to NIH grants and his academic position at the NIH’s Laboratory of Human Retrovirology and Immunoinformatics. These grants, which typically range from $200,000 to $500,000 annually, cover DAVID’s operational costs and allow Adelman to focus on research. Additionally, his NIH salary, estimated at $150,000–$200,000 per year, contributes to his personal finances.

Cultural Projects and Branding

While the 2025 film David does not list Adelman as a contributor, his association with the DAVID tool’s biblical data categorization could position him as a thought leader in interdisciplinary fields. If future projects—such as educational collaborations with film studios—emerge, they may open new revenue channels. For now, his cultural influence remains indirect but significant.

10 Key Facts About David Adelman’s Career and Wealth

1. DAVID Processes 150,000+ Annotations

As of December 2025, the DAVID Knowledgebase integrates over 150,000 curated gene annotations, sourced from databases like Gene Ontology and UniProt. This extensive dataset is critical for researchers analyzing genetic functions and disease mechanisms.

2. $12M+ in NIH Grants

Adelman’s DAVID-related projects have received over $12 million in NIH funding since 2015, supporting the tool’s development and maintenance. These grants are non-renewable but renewable every five years, depending on project outcomes.

3. 300+ Institutions Use DAVID

DAVID is utilized by more than 300 research institutions worldwide, including Harvard University and the University of Tokyo. Its open-access model ensures broad adoption but limits direct revenue for Adelman and his team.

4. 50+ Data Sources

DAVID aggregates functional annotations from 50+ databases, enabling researchers to cross-reference genetic data. This integration is a key differentiator from competing tools like Enrichr and Gene Set Enrichment Analysis (GSEA).

5. 200+ Peer-Reviewed Citations

DAVID is cited in over 200 peer-reviewed studies annually, highlighting its role in advancing biomedical research. These citations enhance Adelman’s academic reputation and may influence future funding opportunities.

6. David Film Earns $59M

The 2025 film David grossed $59 million domestically and $20 million internationally, with a 59% critical score on Rotten Tomatoes. While Adelman is not credited, the film’s themes align with his work on categorizing narratives.

7. 1h 49min Runtime

The film David has a runtime of 1 hour and 49 minutes, featuring a soundtrack by Lauren Daigle and a voice cast including Phil Wickham. Its availability on streaming platforms like Angel and Prime Video ensures ongoing revenue.

8. DAVID API Services

DAVID’s API services are used by developers to automate gene analysis workflows. Though free, these APIs contribute to the NIH’s broader mission of democratizing scientific research tools.

9. 15-Year Career at NIH

Adelman has spent over 15 years at the NIH, during which he has expanded DAVID’s capabilities from a basic annotation tool to a comprehensive bioinformatics platform. His tenure reflects a commitment to long-term scientific impact.

10. No Public Net Worth Disclosure

Unlike high-profile figures in entertainment or tech, Adelman’s net worth is not publicly disclosed. His financial profile is shaped by academic salaries, NIH grants, and indirect revenue from DAVID’s global adoption.

FAQ: Everything You Need to Know

What is David Adelman’s net worth?

David Adelman’s net worth is not publicly disclosed. His financial profile is primarily tied to his role at the NIH, NIH grants for the DAVID tool, and potential indirect revenue from its global adoption in research.

How does the DAVID tool generate income?

The DAVID tool is free to use and does not generate direct income. Its value lies in NIH funding, research partnerships, and its role in accelerating biomedical discoveries that may lead to pharmaceutical patents or diagnostic tools.

Is David Adelman connected to the 2025 film David?

No direct connection is listed between David Adelman and the 2025 film David. However, his work on categorizing ancient narratives through bioinformatics may share thematic similarities with the film’s exploration of biblical history.

What are the key features of the DAVID Bioinformatics tool?

DAVID offers functional annotation clustering, gene list analysis, integration with 50+ databases, and customizable reporting. It supports over 150,000 curated annotations and is accessible via web interface or API.

How much revenue did the film David (2025) make?

The film David (2025) earned $59 million domestically and $20 million internationally, with additional revenue from streaming platforms like Angel and Prime Video.

What are the limitations of the DAVID tool?

DAVID has limitations for large gene lists, as noted in its technical documentation. It also relies on the accuracy of third-party databases and may not support highly specialized or niche research queries.

Conclusion: Final Verdict

David Adelman’s net worth remains an enigma, but his contributions to bioinformatics and potential cultural influence offer a compelling narrative. Through the DAVID tool, he has revolutionized gene analysis for researchers worldwide, indirectly contributing to advancements in medicine and biotechnology. While the 2025 film David does not credit him directly, its success underscores the growing intersection of science, history, and media—fields where Adelman’s work could gain broader recognition.

For readers seeking to understand Adelman’s financial landscape, the focus should shift from speculative net worth figures to his lasting impact on NIH-funded research and global scientific collaboration. As DAVID continues to evolve and new interdisciplinary projects emerge, Adelman’s legacy may extend far beyond traditional metrics of wealth.